Yongli Bao
- Cancer Research top 10%
- Molecular Biology top 10%
- Histone Deacetylase Inhibitors Research 8
- Natural product bioactivities and synthesis 8
- Metabolism, Diabetes, and Cancer 7
- TGF-β signaling in diseases 7
- Epigenetics and DNA Methylation 7
- Plant biochemistry and biosynthesis 6
- RNA Research and Splicing 6
- Biochemistry top 10%
- Pharmacology top 5%
-
- Nuts composition and effects 6
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (2 papers)PLoS ONE (2 papers)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Yongli Bao
103 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 123
- Cancer Research 274
- Molecular Biology 1.1k
- Biochemistry 82
- Complementary and alternative medicine 104
- Pharmacology 104
Countries citing papers authored by Yongli Bao
This map shows the geographic impact of Yongli Bao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongli Bao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongli Bao more than expected).
Fields of papers citing papers by Yongli Bao
This network shows the impact of papers produced by Yongli Bao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongli Bao. The network helps show where Yongli Bao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yongli Bao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 23 | |
| 2 | 2024 | 13 | |
| 3 | 2024 | 22 | |
| 4 | 2023 | 8 | |
| 5 | 2023 | 19 | |
| 6 | 2021 | 3 | |
| 7 | 2021 | 24 | |
| 8 | 2020 | 7 | |
| 9 | 2019 | 11 | |
| 10 | 2019 | 37 | |
| 11 | 2017 | 15 | |
| 12 | 2017 | 49 | |
| 13 | 2016 | 7 | |
| 14 | 2016 | 20 | |
| 15 | 2016 | 13 | |
| 16 | 2016 | 31 | |
| 17 | 2014 | 2 | |
| 18 | 2013 | 19 | |
| 19 | 2012 | 24 | |
| 20 | 2012 | 9 |
About Yongli Bao
Yongli Bao is a scholar working on Cancer Research, Toxicology and Molecular Biology, having authored 107 papers that have together received 2.0k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (8 papers), Natural product bioactivities and synthesis (8 papers), Metabolism, Diabetes, and Cancer (7 papers), TGF-β signaling in diseases (7 papers), Epigenetics and DNA Methylation (7 papers), Plant biochemistry and biosynthesis (6 papers), Nuts composition and effects (6 papers) and RNA Research and Splicing (6 papers). The work is most often cited by research in Cancer Research (274 citations), Molecular Biology (1.1k citations) and Biochemistry (82 citations). Yongli Bao has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Chunlei Yu, Yanxin Huang, Zhenbo Song, Yuxin Li, Yin Wu, Luguo Sun, Lihua Zheng, Jingwen Yi, Kunihiro Tsuchida and Lei Liu. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.